[Augmentation by succinylcholine of the neuromuscular blocking effect of vecuronium in children]

Area of Science:

• Anesthesiology
• Pharmacology
• Pediatric Medicine

Background:

• Vecuronium is a common neuromuscular blocking agent used in pediatric anesthesia.
• The potential for drug interactions affecting neuromuscular blockade requires careful evaluation.

Purpose of the Study:

• To assess the impact of succinylcholine (Scc) on the efficacy of subsequent vecuronium administration in children.
• To determine if Scc pre-administration enhances or alters vecuronium's neuromuscular blocking properties.

Main Methods:

• A study involving 30 pediatric patients (aged 2-14 years) undergoing elective surgery.
• Patients received either vecuronium alone (Group V) or vecuronium after full recovery from Scc-induced blockade (Group SV).
• Neuromuscular blockade was monitored using train-of-four stimulation and an acceleration transducer measuring adductor pollicis muscle response.

Main Results:

• Group SV exhibited a shorter onset of action and potentiation of maximal neuromuscular block compared to Group V.
• Complete suppression of T1 (first twitch) after vecuronium was observed in 8 patients in Group SV versus only 1 patient in Group V.
• Prior Scc administration significantly enhanced the neuromuscular blockade duration and intensity.

Conclusions:

• Succinylcholine (Scc) administration prior to vecuronium significantly potentiates its neuromuscular blocking effect in pediatric patients.
• This potentiation suggests a synergistic interaction that may allow for reduced vecuronium dosage or prolonged blockade.
• The findings have implications for optimizing neuromuscular blockade management in pediatric surgical settings.